Wednesday, March 29, 2023

Congressman Sounds Alarm Over Department of Veterans Affairs Purchasing Drugs From China

By Ross Muscato

March 24, 2023  Updated: March 28, 2023

 Nghị sĩ lên tiếng báo động về việc mua thuốc từ Trung Quốc của Bộ Sự vụ Cựu chiến binh

Rep. Greg Murphy (R-N.C.), in his questioning of and conversation with Department of Veterans Affairs (VA) Secretary Denis McDonough during the March 23 House Committee on Veterans Affairs hearing, pressed the secretary on an issue which the congressman called an “absolute danger” to the United States.  

Murphy, who is a physician, was referring to the decision that the VA made and the policy it adopted in 2016 to purchase drugs that include active ingredients that come from China, which are then prescribed and given to veterans.  

“I don’t understand this policy,” said Murphy. “And we’re now … allowing drugs to come to our veterans, as well as other drugs coming into this country, that are not being analyzed, that are not being reviewed, are not being inspected.  And this is an absolute troubling thing to me as a physician.”  

Murphy, a member of the Veterans Affairs committee, always has veterans’ issues front and center on his lawmaking and advocacy radar screen. 

The district he represents has among the highest percentage of its residents who are veterans of any congressional district in the nation: one in seven.  

Then there are those in Murphy’s district who are in military active service.  Murphy’s district includes Marine Corps Base Camp Lejeune, Marine Corps Air Station Cherry Point, Marine Corps Air Station New River, and Coast Guard Sector Field Office Fort Macon.

The exchange between Murphy and McDonough took place at the hearing, which focused on assessing the Biden administration’s proposed budget for the VA for 2024 and 2025.  

The congressman learned from a conversation he had with McDonough prior to the hearing that the secretary was unaware that the VA approved as vendors pharmaceutical companies which use components from China in the manufacture of their products.  

Murphy brought up that he attended that morning a meeting of the GOP Doctors Caucus at which members “talked about drugs in this country from China; 90 percent of our APIs, active pharmaceutical ingredients, come from China today—and our FDA is doing an absolute abysmal job in looking at these drugs; seeing their purity, seeing their impurity.” 

Security Threat 

March 1 story in The Epoch Times reported on how the Chinese Communist Party (CCP) supplies most of the drug precursors processed in Mexico into the deadly drug fentanyl, and most of the illegal fentanyl in the United States comes from Mexico.   

Bộ trưởng Bộ Cựu chiến binh Denis McDonough diễn thuyết tại Hoa Thịnh Đốn vào ngày 09/11/2021. (Ảnh: Anna Moneymaker/Getty Images)

Secretary of Veterans Affairs Denis McDonough speaks in Washington on Nov. 9, 2021. (Anna Moneymaker/Getty Images)

Murphy said that beyond the injury and threat to the health of veterans posed by the VA purchasing drugs made from ingredients that the CCP provides, the policy imperils the security of the nation. 

“And we now, like it or not, ballistic or not, are at war with our greatest adversary,” said Murphy. “We saw this with the balloon.  We saw this with the absolute flood of fentanyl coming into this country from China.”

Murphy continued, imploring McDonough to research and look into the matter of VA and its program that buys drugs sourced from China.

“I would like a commitment from you, and I know I can stand by this—that this issue will be researched because it is absolutely—I’m ineffable about this; I can’t understand why this was done.”

Murphy asked McDonough to see if there was any way that the VA could “get out” of the drug contract it entered into in 2016, and “I think for the sake of our veterans, we need to explore that.”

McDonough replied, “Yeah, you got my commitment, Mr. Murphy.”

 

https://www.theepochtimes.com/congressman-sounds-alarm-over-department-of-veterans-affairs-va-purchasing-drugs-from-china_5146335.html

No comments:

Post a Comment